These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 6125131)

  • 1. Involvement of the dopaminergic system in the regulation of the caudate spindle in the rat.
    Kamata K; Aoki H; Kameyama T
    Arch Int Pharmacodyn Ther; 1982 Apr; 256(2):228-35. PubMed ID: 6125131
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of intracerebral morphine and enkephalins on the caudate-EEG spindle burst.
    Kamata K; Kameyama T
    Arch Int Pharmacodyn Ther; 1985 May; 275(1):68-77. PubMed ID: 4026463
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of intracerebral administration of atropine and morphine on the caudate stimulation-induced caudate spindle in rats.
    Kamata K; Aoki H; Kameyama T
    J Pharmacobiodyn; 1981 Oct; 4(10):788-93. PubMed ID: 7320830
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Haloperidol and apomorphine differentially affect neuropeptidase activity.
    Waters SM; Konkoy CS; Davis TP
    J Pharmacol Exp Ther; 1996 Apr; 277(1):113-20. PubMed ID: 8613907
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of cholinergic and GABAergic drugs on apomorphine-induced gnawing behavior in rats.
    Rastogi SK; Rastogi RB; Singhal RL; Lapierre YD
    Biol Psychiatry; 1982 Aug; 17(8):937-46. PubMed ID: 6288127
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modification of apomorphine-, physostigmine- and pilocarpine-induced yawning after long-term treatment with neuroleptic or cholinergic agents.
    Ushijima I; Noda Y; Mizuki Y; Yamada M
    Arch Int Pharmacodyn Ther; 1984 Oct; 271(2):180-8. PubMed ID: 6150689
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cholecystokinin release from the rat caudate-putamen, cortex and hippocampus is increased by activation of the D1 dopamine receptor.
    Brog JS; Beinfeld MC
    J Pharmacol Exp Ther; 1992 Jan; 260(1):343-8. PubMed ID: 1346163
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A model for the quantitative study of central dopaminergic and serotoninergic activity.
    Bieger D; Larochelle L; Hornykiewicz O
    Eur J Pharmacol; 1972 Apr; 18(1):128-36. PubMed ID: 4555562
    [No Abstract]   [Full Text] [Related]  

  • 9. Dopaminergic and serotonergic mechanisms of thermoregulation: mediation of thermal effects of apomorphine and dopamine.
    Yamawaki S; Lai H; Horita A
    J Pharmacol Exp Ther; 1983 Nov; 227(2):383-8. PubMed ID: 6631720
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug interactions with dopamin-stimulated adenylate cyclasses of caudate nucleus and retina: direct agonist effect of a piribedil metabolite.
    Makman MH; Mishra RK; Brown JH
    Adv Neurol; 1975; 9():213-22. PubMed ID: 807088
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gamma-type endorphins and brain dopaminergic systems.
    van Ree JM; Elands J; Kiraly I; Wolterink G
    Prog Clin Biol Res; 1990; 328():287-90. PubMed ID: 1968266
    [No Abstract]   [Full Text] [Related]  

  • 12. Interrelations between dopaminergic and GABA-ergic transmitter mechanisms in apomorphine stereotypy.
    Markovska V; Georgiev V
    Acta Physiol Pharmacol Bulg; 1982; 8(3):67-73. PubMed ID: 6820612
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional interaction between serotonin-S2 and dopamine-D2 neurotransmission as revealed by selective antagonism of hyper-reactivity to tryptamine and apomorphine.
    Awouters F; Niemegeers CJ; Megens AA; Janssen PA
    J Pharmacol Exp Ther; 1990 Sep; 254(3):945-51. PubMed ID: 1697623
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The influence of antiserotonergic agents on the action of dopaminergic drugs.
    Mogilnicka E; Scheel-Krüger J; Klimek V; Golembiowska-Nikitin K
    Pol J Pharmacol Pharm; 1977; 29(1):31-8. PubMed ID: 140371
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibitory effect of dopamine on acetylcholine release from caudate nucleus.
    Vizi SE; Rónai A; Hársing L; Knoll J
    Pol J Pharmacol Pharm; 1977; 29(3):201-11. PubMed ID: 887499
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Pharmacological modification of evoked caudate nucleus potentials].
    Lehmann K; Andreas K
    Acta Biol Med Ger; 1979; 38(9):1323-30. PubMed ID: 550668
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhancing effect of taurine on the rat caudate spindle. I: Interaction of taurine with the nigro-striatal dopamine system.
    Hashimoto-Kitsukawa S; Okuyama S; Aihara H
    Pharmacol Biochem Behav; 1988 Oct; 31(2):411-6. PubMed ID: 3244718
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Apomorphine-induced and pilocarpine-induced hypothermia in mice: drug interactions and changes in drug sensitivity after caudate nucleus lesions.
    Glick SD; Marsanico RG
    Br J Pharmacol; 1974 Jul; 51(3):353-7. PubMed ID: 4451749
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Central action of narcotic analgesics. VIII. The effect of dopaminergic stimulants on the action of analgesics in rats.
    Malec D; Langwiński R
    Pol J Pharmacol Pharm; 1981 Oct; 33(3):273-82. PubMed ID: 6119681
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dopamine electrophysiology of ventral pallidal/substantia innominata neurons: comparison with the dorsal globus pallidus.
    Napier TC; Simson PE; Givens BS
    J Pharmacol Exp Ther; 1991 Jul; 258(1):249-62. PubMed ID: 1677041
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.